{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:32Z","timestamp":1787181872168,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019599","name":"European Partnership on Metrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119832","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:30:59Z","timestamp":1785853859000},"page":"119832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3041-1156","authenticated-orcid":false,"given":"Metka","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-4624","authenticated-orcid":false,"given":"Bernarda","family":"Majc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija Skoblar","family":"Vidmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2980-5218","authenticated-orcid":false,"given":"\u0160pela","family":"Kladnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Kolenc","family":"Milavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamarija","family":"Habi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Katrin","family":"Galun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0187-4191","authenticated-orcid":false,"given":"Pia","family":"\u017di\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Por\u010dnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9933-8495","authenticated-orcid":false,"given":"Alenka","family":"Matja\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-7690","authenticated-orcid":false,"given":"Andrej","family":"Zupan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Jerala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-7518","authenticated-orcid":false,"given":"Matic","family":"Bo\u0161njak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Prestor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Breznik","family":"Vittori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 16","key":"10.1016\/j.biopha.2026.119832_bib1","first-page":"3950","article-title":"Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I\/II trial","volume":"16","author":"Weathers","year":"2025","journal-title":"Nat. Commun. 2025"},{"key":"10.1016\/j.biopha.2026.119832_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.03.012","article-title":"Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma","volume":"29","author":"Wei","year":"2016","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119832_bib3","first-page":"325","article-title":"A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center","volume":"8","author":"Noch","year":"2021","journal-title":"Neurooncol. Pract."},{"issue":"4 119","key":"10.1016\/j.biopha.2026.119832_bib4","first-page":"487","article-title":"Detection of circulating tumour cell clusters in human glioblastoma","volume":"119","author":"Krol","year":"2018","journal-title":"Br. J. Cancer 2018"},{"key":"10.1016\/j.biopha.2026.119832_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/awz044","article-title":"The landscape of the mesenchymal signature in brain tumours","volume":"142","author":"Behnan","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119832_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/2159-8290.CD-14-0471","article-title":"Brain tumor cells in circulation are enriched for mesenchymal gene expression","volume":"4","author":"Sullivan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119832_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/neuonc\/noab212","article-title":"TGF-\u03b2 promotes microtube formation in glioblastoma through thrombospondin 1","volume":"24","author":"Joseph","year":"2022","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","article-title":"TGF-\u03b2 increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma","volume":"15","author":"Pe\u00f1uelas","year":"2009","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119832_bib9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/neuonc\/noy078","article-title":"A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098","volume":"20","author":"Brown","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00432-022-04483-3","article-title":"Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo","volume":"149","author":"Houweling","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40478-024-01834-8","article-title":"Efficacy of BRAF\/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation","volume":"12","author":"Steininger","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2026.119832_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12885-023-10996-y","article-title":"Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas","volume":"23","author":"Armstrong","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119832_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11060-023-04260-3","article-title":"The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl\/6-Gl261 mouse glioma model","volume":"161","author":"Ortiz-Rivera","year":"2023","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.biopha.2026.119832_bib14","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/neuonc\/noy078","article-title":"A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098","volume":"20","author":"Brown","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/neuonc\/now009","article-title":"A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma","volume":"18","author":"Brandes","year":"2016","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2024.11.010","article-title":"Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy","volume":"32","author":"Logun","year":"2025","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.biopha.2026.119832_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119832_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110604","article-title":"Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma","volume":"27","author":"Majc","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2026.119832_bib19","article-title":"Modelling brain tumours with organoids: towards precision medicine in neuro-oncology","author":"de Lucas Sanz","year":"2026","journal-title":"Nat. Rev. Neurol. 2026 119"},{"key":"10.1016\/j.biopha.2026.119832_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101173","article-title":"Generation of human induced pluripotent stem cell-derived cerebral organoids for cellular and molecular characterization","volume":"3","author":"Anastasaki","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.biopha.2026.119832_bib21","article-title":"The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression","volume":"7","author":"Novak","year":"2025","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.biopha.2026.119832_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib23","article-title":"Trametinib in combination with temozolomide inhibits GBM cell invasion into cerebral organoids","author":"Majc","year":"2026","journal-title":"BioImage Arch. Database Prepr."},{"key":"10.1016\/j.biopha.2026.119832_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2024.103927","article-title":"Breaking boundaries: a rare case of glioblastoma with uncommon extraneural metastases: a case report and literature review","volume":"4","author":"Taule","year":"2024","journal-title":"Brain Spine"},{"key":"10.1016\/j.biopha.2026.119832_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-011-0731-1","article-title":"Metastatic glioblastoma: case presentations and a review of the literature","volume":"107","author":"Kalokhe","year":"2012","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.biopha.2026.119832_bib26","first-page":"1","article-title":"TERT promoter alterations in glioblastoma: a systematic review","volume":"13","author":"Olympios","year":"2021","journal-title":"Cancers 2021"},{"key":"10.1016\/j.biopha.2026.119832_bib27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00401-013-1163-0","article-title":"TERT promoter mutations in primary and secondary glioblastomas","volume":"126","author":"Nonoguchi","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"5 24","key":"10.1016\/j.biopha.2026.119832_bib28","first-page":"556","article-title":"ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade","volume":"24","author":"Shen","year":"2018","journal-title":"Nat. Med. 2018"},{"key":"10.1016\/j.biopha.2026.119832_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12885-020-6540-1","article-title":"Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report","volume":"20","author":"Umphlett","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119832_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10014-025-00503-5","article-title":"Rapidly progressive scalp and lung metastases with fatal pneumothorax in glioblastoma, IDH-wildtype, with MET and CDK6 amplifications: a case report of clinical course and postmortem autopsy, including genetic analysis","volume":"42","author":"Tsukamoto","year":"2025","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.biopha.2026.119832_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12575-024-00238-1","article-title":"PMS2 amplification contributes brain metastasis from lung cancer","volume":"26","author":"Chen","year":"2024","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.biopha.2026.119832_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119832_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119832_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","article-title":"Proteogenomic and metabolomic characterization of human glioblastoma","volume":"39","author":"Wang","year":"2021","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119832_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/neuonc\/noac177","article-title":"DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients","volume":"25","author":"Drexler","year":"2023","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00401-023-02677-8","article-title":"Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma","volume":"147","author":"Drexler","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"1 24","key":"10.1016\/j.biopha.2026.119832_bib37","first-page":"58","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer 2025"},{"key":"10.1016\/j.biopha.2026.119832_bib38","first-page":"949","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature 2002"},{"key":"10.1016\/j.biopha.2026.119832_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12885-023-10996-y","article-title":"Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas","volume":"23","author":"Armstrong","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119832_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-019-1269-x","article-title":"MET in glioma: signaling pathways and targeted therapies","volume":"38","author":"Cheng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.biopha.2026.119832_bib41","article-title":"FAK in cancer: from mechanisms to therapeutic strategies","volume":"23","author":"Chuang","year":"2022","journal-title":"Int. J. Mol. Sci. 2022"},{"issue":"2 30","key":"10.1016\/j.biopha.2026.119832_bib42","first-page":"153","article-title":"Phosphorylation of focal adhesion kinase on tyrosine 194 by Met leads to its activation through relief of autoinhibition","volume":"30","author":"Chen","year":"2010","journal-title":"Oncogene 2011"},{"issue":"25","key":"10.1016\/j.biopha.2026.119832_bib43","article-title":"The TGF-\u03b2 Family in Glioblastoma","volume":"25","author":"Gol\u00e1n-Cancela","year":"2024","journal-title":"Int. J. Mol. Sci. 2024"},{"issue":"3","key":"10.1016\/j.biopha.2026.119832_bib44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4103\/NRR.NRR-D-24-01639","article-title":"Human cerebral organoids: complex, versatile, and human-relevant models of neural development and brain diseases","volume":"21","author":"Coronel","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119832_bib45","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1038\/s44319-025-00619-x","article-title":"Increased reproducibility of brain organoids through controlled fluid dynamics","volume":"26","author":"Aiello","year":"2025","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119832_bib46","first-page":"173","article-title":"Spatio-temporal dynamics enhance cellular diversity, neuronal function and further maturation of human cerebral organoids","volume":"6","author":"Saglam-Metiner","year":"2023","journal-title":"Commun. Biol. 2023"},{"key":"10.1016\/j.biopha.2026.119832_bib47","first-page":"1010","article-title":"Morphodynamics of human early brain organoid development","volume":"644","author":"Jain","year":"2025","journal-title":"Nature 2025"},{"key":"10.1016\/j.biopha.2026.119832_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1078-0432.CCR-18-1580","article-title":"Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib","volume":"25","author":"Berberich","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119832_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17050549","article-title":"Drug combinations targeting FAK and MEK overcomes tumor heterogeneity in glioblastoma","volume":"17","author":"Furqan","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119832_bib50","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119832_bib51","first-page":"1","article-title":"Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma","volume":"5","author":"Khan","year":"2023","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119832_bib52","first-page":"436","article-title":"Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres","volume":"5","author":"Breznik","year":"2022","journal-title":"Commun. Biol. 2022"},{"key":"10.1016\/j.biopha.2026.119832_bib53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12885-023-10996-y","article-title":"Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas","volume":"23","author":"Armstrong","year":"2023","journal-title":"BMC Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:43:23Z","timestamp":1787179403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S0753332226008681"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119832","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119832"}}